Literature DB >> 34329449

Procalcitonin in Pediatric Sepsis: What Is It Good for?

Kevin J Downes1,2,3,4.   

Abstract

Entities:  

Keywords:  antibiotics; biomarker; children; sepsis

Mesh：

Substances：

Year:  2021        PMID： 34329449      PMCID： PMC8719609          DOI： 10.1093/jpids/piab066

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   5.235


× No keyword cloud information.
  19 in total

1.  Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.

Authors:  Fei Peng; Wei Chang; Jian-Feng Xie; Qin Sun; Hai-Bo Qiu; Yi Yang
Journal:  Int J Infect Dis       Date:  2019-06-21       Impact factor: 3.623

2.  A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections.

Authors:  Nathan Kuppermann; Peter S Dayan; Deborah A Levine; Melissa Vitale; Leah Tzimenatos; Michael G Tunik; Mary Saunders; Richard M Ruddy; Genie Roosevelt; Alexander J Rogers; Elizabeth C Powell; Lise E Nigrovic; Jared Muenzer; James G Linakis; Kathleen Grisanti; David M Jaffe; John D Hoyle; Richard Greenberg; Rajender Gattu; Andrea T Cruz; Ellen F Crain; Daniel M Cohen; Anne Brayer; Dominic Borgialli; Bema Bonsu; Lorin Browne; Stephen Blumberg; Jonathan E Bennett; Shireen M Atabaki; Jennifer Anders; Elizabeth R Alpern; Benjamin Miller; T Charles Casper; J Michael Dean; Octavio Ramilo; Prashant Mahajan
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

3.  Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis.

Authors:  Dominique J Pepper; Junfeng Sun; Chanu Rhee; Judith Welsh; John H Powers; Robert L Danner; Sameer S Kadri
Journal:  Chest       Date:  2019-02-14       Impact factor: 9.410

4.  Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study.

Authors:  Kevin J Downes; Julie C Fitzgerald; Emily Schriver; Craig L K Boge; Michael E Russo; Scott L Weiss; Fran Balamuth; Sherri E Kubis; Pam Tolomeo; Warren B Bilker; Jennifer H Han; Ebbing Lautenbach; Susan E Coffin; Jeffrey S Gerber
Journal:  J Pediatric Infect Dis Soc       Date:  2020-02-28       Impact factor: 3.164

5.  Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates.

Authors:  C Chiesa; A Panero; N Rossi; M Stegagno; M De Giusti; J F Osborn; L Pacifico
Journal:  Clin Infect Dis       Date:  1998-03       Impact factor: 9.079

6.  Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection.

Authors:  N G Morgenthaler; J Struck; Y Chancerelle; W Weglöhner; D Agay; C Bohuon; V Suarez-Domenech; A Bergmann; B Müller
Journal:  Horm Metab Res       Date:  2003-05       Impact factor: 2.936

7.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

8.  The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.

Authors:  Lin Ruan; Guan-Yu Chen; Zhen Liu; Yun Zhao; Guang-Yu Xu; Shu-Fang Li; Chun-Ni Li; Lin-Shan Chen; Zheng Tao
Journal:  Crit Care       Date:  2018-11-21       Impact factor: 9.097

9.  Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis.

Authors:  Yutaka Kondo; Yutaka Umemura; Kei Hayashida; Yoshitaka Hara; Morio Aihara; Kazuma Yamakawa
Journal:  J Intensive Care       Date:  2019-04-15

10.  Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis.

Authors:  Seo Hee Yoon; Eun Hwa Kim; Ha Yan Kim; Jong Gyun Ahn
Journal:  BMC Infect Dis       Date:  2019-08-30       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.